Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMTX compared with URGN: revenue, margins and what each company keeps, and the suppliers and customers both name
IMTX
Immatics N.V.
Change
Mkt cap
Revenue
Revenue
URGN
UroGen Pharma Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMTX
Immatics N.V.
vs
URGN
UroGen Pharma Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
IMTX
No earnings history for IMTX.
URGN
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±14.0%
▼
−16.45%
×1.17
Q2 FY26
±16.0%
▲
+16.31%
×1.02
May 6 '26
±16.0%
▲
+10.16%
×0.64
Q1 FY26
±20.4%
▼
−12.35%
×0.60
= implied
IMTX realized, solid
URGN realized, hatched
One scale, both sides: full bar = 21%
× = |realized| ÷ implied
Source: market data
IMTX
Immatics N.V.
Change
6.34
▲
+2.65%
· post 6.34
Mkt cap
$852.7M
Revenue
—
Revenue
—
URGN
UroGen Pharma Ltd.
Change
24.77
▼
−3.72%
· post 24.38
Closed
Nov 6 '26
Mkt cap
$1.2B
Revenue
$89M
Q3 FY26
Revenue
$110M
FY25
vs
Compare
Closed
Nov 6 '26
IMTX
Immatics N.V.
vs
URGN
UroGen Pharma Ltd.
6.34
▲
+2.65%
post 6.34
Price
24.77
▼
−3.72%
post 24.38
$852.7M
Mkt cap
$1.2B
—
Revenue
$89M
Q3 FY26
—
Revenue
$110M
FY25
Change
Change
IMTX
6.34
▲
+2.65%
vs
URGN
24.77
▼
−3.72%
Closed
Nov 6 '26